Finance

Lists
524572:BOM
Pharmaids Pharmaceuticals Ltd
₹30,59
+0,46%
(+0,14) 1D
16 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524572...
Open
₹30,35
High
₹32,50
Low
₹29,80
Mkt. cap
1,06 mjd
Avg. vol.
3,45 k
Volume
3,76 k
52-wk high
₹53,90
52-wk low
₹25,60
EPS
-₹1,29
Shares outstanding
3,41 m
No. of employees
127
Open
₹30,35
High
₹32,50
Low
₹29,80
Mkt. cap
1,06 mjd
Avg. vol.
3,45 k
Volume
3,76 k
52-wk high
₹53,90
52-wk low
₹25,60
EPS
-₹1,29
Shares outstanding
3,41 m
No. of employees
127
News stories
From web sources and news partners
About Pharmaids Pharmaceuticals Ltd
CEO-
Employees127
Founded1989
Headquarters-
SectorPharmaceutical industry
Websitepharmaids.com
Last report
12 Aug. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
41,21 m / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
86,05 m
54,30 m
71,84 m
41,21 m
Cost of goods sold
75,50 m
23,48 m
45,15 m
16,17 m
Cost of revenue
75,50 m
23,48 m
45,15 m
16,17 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31,81 m
32,83 m
76,78 m
24,66 m
Operating expense
68,44 m
60,62 m
34,80 m
37,34 m
Total operating expenses
143,95 m
84,10 m
79,94 m
53,52 m
Operating income
-57,90 m
-29,80 m
-8,11 m
-12,30 m
Other non operating income
2,22 m
760,00 k
-2,73 m
483,00 k
EBT including unusual items
-36,57 m
-40,22 m
-14,56 m
24,14 m
EBT excluding unusual items
-66,45 m
-36,22 m
-12,62 m
-17,86 m
Income tax expense
-11,29 m
-13,76 m
-3,71 m
5,43 m
Effective tax rate
30,87%
34,20%
25,48%
22,49%
Other operating expenses
31,96 m
23,04 m
-46,75 m
7,83 m
Net income
-24,80 m
-24,79 m
-18,09 m
22,05 m
Net profit margin
-28,83%
-45,65%
-25,18%
53,51%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1,54 m
-
Interest expense
-10,77 m
-7,18 m
-4,36 m
-6,04 m
Net interest expenses
-10,77 m
-7,18 m
-2,82 m
-6,04 m
Depreciation and amortization charges
4,68 m
4,76 m
4,77 m
4,86 m
EBITDA
-52,53 m
-25,07 m
-4,50 m
-7,23 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme